Flora Growth (FLGC) Stock Price, News & Analysis

Company Overview

Flora Growth Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.

Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida. This geographic footprint enables the company to supply regulated markets across the Americas and to explore select opportunities in Europe and Latin America through both branded and private-label channels.

The company places a strong emphasis on research and development, with a multidisciplinary team dedicated to advancing nanoemulsion technologies, transdermal patches and other novel delivery methods. These R&D efforts aim to improve product efficacy in areas such as pain management, dermatology and general wellness, while complying with evolving regulatory standards.

Headquartered in Vancouver, British Columbia, with regional offices in Montevideo and Miami, Flora Growth is led by Chairman and CEO Richard Pattison. Under his guidance, the management team leverages deep expertise in agronomy, bioprocessing and international business development to navigate complex market dynamics and drive long-term growth.

Key Stats

• Today's Range: $4.42 to $6.74
• 50-Day Range: $1.35 to $5.89
• 52-Week Range: $5.86 to $47.00
• Volume: 463,870 shs
• Average Volume: 39,454 shs
• Market Capitalization: $4.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Flora Growth Stock Analysis - MarketRank™

Flora Growth scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Flora Growth has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Flora Growth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Flora Growth are expected to grow in the coming year, from ($0.93) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Flora Growth is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Flora Growth is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Flora Growth has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for FLGC.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Flora Growth does not currently pay a dividend.

Dividend Growth

Flora Growth does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added Flora Growth to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Flora Growth insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.34% of the stock of Flora Growth is held by insiders.

Percentage Held by Institutions

36.01% of the stock of Flora Growth is held by institutions.

Company Calendar

• Last Earnings: 11/05/2025
• Today: 8/23/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:FLGC
• CIK: 1790169
• Web: floragrowth.ca
• Phone: 954-842-4989
• Fax: N/A
• Employees: 280
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($32.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.91 million
• Net Margins: -32.03%
• Pretax Margin: -29.29%
• Return on Equity: -64.02%
• Return on Assets: -34.46%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.08
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $57.61 million
• Price / Sales: 0.09
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $12.21 per share
• Price / Book: 0.39

Miscellaneous

• Outstanding Shares: 1,046,000
• Free Float: 1,022,000
• Market Cap: $4.93 million
• Optionable: Not Optionable
• Beta: 1.90